Plasmid-chromosome transcriptional crosstalk in multidrug resistant clinical enterobacteria

Abstract

AbstractConjugative plasmids promote the dissemination and evolution of antimicrobial resistance in bacterial pathogens. However, plasmid acquisition can produce physiological alterations in the bacterial host, leading to potential fitness costs that determine the clinical success of bacteria-plasmid associations. In this study, we used a transcriptomic approach to characterize the interactions between a globally disseminated carbapenem resistance plasmid, pOXA-48, and a diverse collection of multidrug resistant clinical enterobacteria. Although pOXA-48 produced mostly strain-specific transcriptional alterations, it also led to the common overexpression of a small chromosomal operon present inKlebsiellaspp. andCitrobacter freundiistrains. This operon included two genes coding for a pirin and an isochorismatase family proteins (pfpandifp), and showed evidence of horizontal mobilization across Proteobacteria species. Combining genetic engineering, transcriptomics, and CRISPRi gene silencing, we showed that a pOXA-48-encoded LysR regulator is responsible for the plasmid-chromosome crosstalk. Crucially, the operon overexpression produced a fitness benefit in a pOXA-48-carryingK. pneumoniaeclinical strain, suggesting that this crosstalk promotes the dissemination of carbapenem resistance in clinical settings.